ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 918

Anergic B Cells May Preserve Peripheral Tolerance in Lupus-Prone Congenic Mice

Kieran Manion1,2, Yuriy Baglaenko1,2, Nan-Hua Chang2, Nafiseh Talaei3 and Joan Wither4, 1Immunology, University of Toronto, Toronto, ON, Canada, 2Genetics and Development, Krembil Research Institute, University Health Network, Toronto, ON, Canada, 3Genetics and Development, Krembil Research Institute, Toronto, ON, Canada, 4Krembil Research Institute, University Health Network, Toronto, ON, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: B cell tolerance, flow cytometry, mouse model and systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: B Cell Biology and Targets in Autoimmune Disease I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:  Anergic autoreactive B cells are thought to play a critical role in systemic lupus erythematosus (SLE), a chronic autoimmune disease where breach of tolerance to nuclear antigen leads to the production of pathogenic anti-nuclear autoantibodies (ANA). There is evidence that anergic B cells survive longer and are less tolerized in SLE patients and lupus-prone mice; however, their exact contribution to SLE pathogenesis remains unclear. Our laboratory has used congenic derivatives of the lupus-prone New Zealand Black mouse to parse the B and T cell defects involved in SLE, uncovering a B cell defect required for ANA production (in the 170.8-181 Mb interval on chromosome 1 [C1d]) as well as T cell defects (in the 124-181 Mb interval [C1b-d]) that exacerbate disease. Since these defects were sufficient to breach B cell anergy to the neo-self antigen hen egg lysozyme, we hypothesized that a similar breach would occur in the Vκ8/3H9 model of anergy, a better analogue for human SLE.

Methods:  The 3H9 heavy chain and Vκ8 light chain were knocked into their correct loci in the C1d and C1b-d strains to generate mice with homogeneous, ssDNA-specific, anergic B cell repertoires. ANAs in female 8 month old non-autoimmune (B6), C1d and C1b-d wild type (WT) and double knock-in (dKI) mice were measured by ELISA, while splenic B and T cells were examined using flow cytometry. Adoptive transfer of B6 or C1d dKI B cells into B6 or C1d WT recipients was conducted to assess the effect of the anergic milieu on B cell activity; recipients were sacrificed after 7 days and splenocytes analyzed via flow cytometry.

Results:  C1b-d WT mice had significantly increased anti-ssDNA IgG and IgM, and higher proportions of germinal centre (GC) B cells, CD86+ B cells and T follicular helper (TFH) cells than B6 WT mice, with C1d WT mice also trending to significance. Surprisingly, the autoimmune B cell phenotype was attenuated in both C1 dKI strains, such that C1 dKI mice were equivalent to B6 counterparts. While the levels of TFH cells remained significantly higher in C1 dKI mice than in B6, they were significantly decreased compared to C1 WT mice, suggesting that the attenuated breach of B cell tolerance could result from insufficient T cell priming. This explanation was supported by the observation that anergic C1d dKI B cells adoptively transferred into C1d WT mice showed similar trends to increased GC and CD86+ B cells as in C1d WT mice. Finally, while the proportion of TFH cells was significantly decreased in C1b-d dKI mice compared to their WT counterparts, the proportion of T follicular regulatory (TFR) cells remained similar to WT levels, suggesting that selective survival or induction of TFR cells in the dKI congenic strains may play a role in their decreased autoimmune phenotype.

Conclusion:  Our results demonstrate that while the B and T cell defects in New Zealand Black congenic mice generate autoimmunity in an unconstrained immune system, these defects are not sufficient to robustly breach tolerance to endogenous nuclear antigen when the B cell repertoire is predominantly anergic, possibly due to modulation of T cell activation or regulatory cell fate.


Disclosure: K. Manion, None; Y. Baglaenko, None; N. H. Chang, None; N. Talaei, None; J. Wither, None.

To cite this abstract in AMA style:

Manion K, Baglaenko Y, Chang NH, Talaei N, Wither J. Anergic B Cells May Preserve Peripheral Tolerance in Lupus-Prone Congenic Mice [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/anergic-b-cells-may-preserve-peripheral-tolerance-in-lupus-prone-congenic-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anergic-b-cells-may-preserve-peripheral-tolerance-in-lupus-prone-congenic-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology